Sex differences in impulsivity and brain morphometry in methamphetamine users.
Methamphetamine (METH) is an addictive stimulant, and METH users have abnormal brain structures and function. The aims of this study were to investigate the relationships between impulsivity, brain structures, and possible sex-specific differences between METH users and non-drug using Controls. Structural MRI and the Barratt Impulsiveness Scale (BIS) questionnaire were completed in 124 subjects: 62 METH (ages 41.2 ± 1.4 years, 34 males) and 62 Controls (ages 43.3 ± 2.3 years, 36 males). Independent and interactive effects of METH use status and sex were evaluated. Relationships between METH usage characteristics, brain morphometry, and impulsivity scores were examined. METH users had higher impulsivity scores, on both the Cognitive and Behavioral Factors from the BIS (p < 0.0001-0.0001). Compared with same-sex Controls, male METH users had larger, while female METH users had smaller, right superior frontal cortex (interaction-p = 0.0005). The male METH users with larger frontal volumes and female METH users with smaller or thinner frontal cortices had greater Cognitive impulsivity (interaction-p ≤ 0.05). Only female METH users showed relatively larger nucleus accumbens (interaction-p = 0.03). Greater impulsivity and thinner frontal cortices in METH users are validated. Larger superior frontal cortex in male METH users with greater cognitive impulsivity suggest decreased dendritic pruning during adolescence might have contributed to their impulsive and drug use behaviors. In the female METH users, smaller frontal cortices and the associated greater impulsivity suggest greater neurotoxicity to these brain regions, while their relatively larger nucleus accumbens suggest an estrogen-mediated neuroprotective glial response. Men and women may be affected differently by METH use.
Department of Medicine, John A. Burns School of Medicine, University of Hawaii and Queen's Medical Center, 1356 Lusitana Street, UH Tower, Room 716, Honolulu, HI, 96813, USA.
Shannon
S
Kogachi
Department of Medicine, John A. Burns School of Medicine, University of Hawaii and Queen's Medical Center, 1356 Lusitana Street, UH Tower, Room 716, Honolulu, HI, 96813, USA. lchang@hawaii.edu.
Linda
L
Chang
Department of Medicine, John A. Burns School of Medicine, University of Hawaii and Queen's Medical Center, 1356 Lusitana Street, UH Tower, Room 716, Honolulu, HI, 96813, USA.
Daniel
D
Alicata
Department of Medicine, John A. Burns School of Medicine, University of Hawaii and Queen's Medical Center, 1356 Lusitana Street, UH Tower, Room 716, Honolulu, HI, 96813, USA.
Eric
E
Cunningham
Department of Medicine, John A. Burns School of Medicine, University of Hawaii and Queen's Medical Center, 1356 Lusitana Street, UH Tower, Room 716, Honolulu, HI, 96813, USA.
Thomas
T
Ernst
D000328:Adult; D019969:Amphetamine-Related Disorders / Q000473:pathology* / Q000523:psychology*; D001921:Brain / Q000187:drug effects / Q000473:pathology*; D005260:Female; D006801:Humans; D007175:Impulsive Behavior / Q000187:drug effects / Q000502:physiology; D008279:Magnetic Resonance Imaging; D008297:Male; D008694:Methamphetamine / Q000009:adverse effects*; D008875:Middle Aged; D010555:Personality Inventory; D012727:Sex Characteristics; D055815:Young Adult
D008694:Methamphetamine
Brain morphometry; Impulsivity; Methamphetamine; Sex differences